Trial to Evaluate the Immunogenicity and Safety of Panblok® (H7 rHA) in Healthy Adults Aged 18 and Older
Clinical trial NCT02464163 · COMPLETED
Trial details
- NCT number
- NCT02464163
- Sponsor
- Protein Sciences Corporation
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2015-07-01
- Primary completion
- 2016-08-01
- Enrollment
- 407
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.